Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Clinical trial NCT00908037 · COMPLETED
Trial details
- NCT number
- NCT00908037
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-30
- Primary completion
- 2014-02-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.